Recent Quotes
My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

United Therapeutics Corporation - Common Stock (NQ:UTHR)

454.00 +6.55 (+1.46%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 376,508
Open 448.00
Bid (Size) 438.45 (40)
Ask (Size) 475.00 (40)
Prev. Close 447.45
Today's Range 445.25 - 456.41
52wk Range 266.98 - 479.50
Shares Outstanding 44,891,523
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
My Top Vanguard Index ETF Pick for 2026
This ETF has underperformed the S&P 500 lately, but I think that will change. 
Via The Motley Fool
Topics ETFs Economy Stocks
The 5 Most Interesting Analyst Questions From United Therapeutics’s Q3 Earnings Call
United Therapeutics delivered a quarter that was well received by the market despite missing revenue expectations, as operational progress and clinical milestones took center stage. Management credited... 
Via StockStory
Topics Earnings Intellectual Property

Performance

YTD
+26.0%
+26.0%
1 Month
-0.6%
-0.6%
3 Month
+51.6%
+51.6%
6 Month
+47.4%
+47.4%
1 Year
+14.2%
+14.2%

More News

Read More
If You Invested $100 In United Therapeutics Stock 5 Years Ago, You Would Have This Much Today
Via Benzinga
Earnings Scheduled For October 29, 2025
Via Benzinga
United Therapeutics Corporation to Present at Upcoming Investor Conferences
From United Therapeutics Corporation
Via Business Wire
United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease
From United Therapeutics Corporation
Via Business Wire
2 Safe-and-Steady Stocks with Impressive Fundamentals and 1 We Avoid
Via StockStory
United Therapeutics Corp (NASDAQ:UTHR) Offers Affordable Growth with Strong Profitability
Via Chartmill
United Therapeutics (UTHR) Earnings Transcript
Via The Motley Fool
Topics Earnings Intellectual Property
Insmed Catapults While IBD 50's Argenx Creeps Higher On Bullish Reports
Via Investor's Business Daily
UTHR Q3 Deep Dive: Clinical Pipeline Advances and High-Dose Product Launches Drive Outlook
Via StockStory
Why Is United Therapeutics (UTHR) Stock Soaring Today
Via StockStory
S&P 500 Tops 6,900 Ahead Fed Rate Move, Gold Reclaims $4,000: What's Moving Markets Wednesday?
Via Benzinga
Topics Economy Stocks
Caterpillar Posts Upbeat Q3 Results, Joins United Therapeutics, Centene, Fortive And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
United Therapeutics Dips As Bread-And-Butter Drug Comes Up Short
Via Investor's Business Daily
United Therapeutics Corp (NASDAQ:UTHR) Reports Q3 2025 Earnings: Revenue Misses, EPS Beats Estimates
Via Chartmill
United Therapeutics (NASDAQ:UTHR) Reports Sales Below Analyst Estimates In Q3 Earnings
Via StockStory
United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results
From United Therapeutics Corporation
Via Business Wire
A Peek at United Therapeutics's Future Earnings
Via Benzinga
United Therapeutics (UTHR) Reports Q3: Everything You Need To Know Ahead Of Earnings
Via StockStory
Topics Artificial Intelligence
If You Invested $100 In United Therapeutics Stock 15 Years Ago, You Would Have This Much Today
Via Benzinga
United Therapeutics Forges Ahead with Share Repurchases, Not Dividends, Following July 2025 Volume Surge
Via MarketMinute
Topics Retirement
United Therapeutics Corp (NASDAQ:UTHR) Meets Key Peter Lynch Investment Criteria
Via Chartmill
United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025
From United Therapeutics Corporation
Via Business Wire
United Therapeutics Corp (NASDAQ:UTHR) Emerges as a Prime Value Investment Candidate
Via Chartmill

Frequently Asked Questions

Is United Therapeutics Corporation - Common Stock publicly traded?
Yes, United Therapeutics Corporation - Common Stock is publicly traded.
What exchange does United Therapeutics Corporation - Common Stock trade on?
United Therapeutics Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for United Therapeutics Corporation - Common Stock?
The ticker symbol for United Therapeutics Corporation - Common Stock is UTHR on the Nasdaq Stock Market
What is the current price of United Therapeutics Corporation - Common Stock?
The current price of United Therapeutics Corporation - Common Stock is 454.00
When was United Therapeutics Corporation - Common Stock last traded?
The last trade of United Therapeutics Corporation - Common Stock was at 11/06/25 04:00 PM ET
What is the market capitalization of United Therapeutics Corporation - Common Stock?
The market capitalization of United Therapeutics Corporation - Common Stock is 20.38B
How many shares of United Therapeutics Corporation - Common Stock are outstanding?
United Therapeutics Corporation - Common Stock has 20B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.